Physical behavior of KR-12 peptide on solid surfaces and Langmuir-Blodgett lipid films: Complementary approaches to its antimicrobial mode against S. aureus

Biochim Biophys Acta Biomembr. 2022 Feb 1;1864(1):183779. doi: 10.1016/j.bbamem.2021.183779. Epub 2021 Sep 21.

Abstract

Biophysical characterization of antimicrobial peptides helps to understand the mechanistic aspects of their action. The physical behavior of the KR-12 antimicrobial peptide (e.g. orientation and changes in secondary structure), was analyzed after interactions with a Staphylococcus aureus membrane model and solid surfaces. We performed antimicrobial tests using Gram-positive S. aureus (ATCC 25923) bacteria. Moreover, Langmuir-Blodgett experiments showed that the synthetic peptide can disturb the lipidic membrane at a concentration lower than the Minimum Inhibitory Concentration, thus confirming that KR-12/lipid interactions are involved. Partially- and fully-deactivated KR-12 hybrid samples were obtained by physisorption and covalent immobilization in chitosan/silica and glyoxal-rich solid supports. The correlation of Langmuir-Blodgett data with the α-helix formation, followed by FTIR-ATR in a frozen-like state, and the antimicrobial activity showed the importance of these interactions and conformation changes on the first step action mode of this peptide. This is the first time that material science (immobilization in solid surfaces assisted by FTIR-ATR analysis in frozen-like state) and physical (Langmuir-Blodgett/Schaefer) approaches are combined for exploring mechanistic aspects of the primary action mode of the KR-12 antimicrobial peptide against S. aureus.

Keywords: Antimicrobial peptide; Bacterial membrane model; Chitosan-glyoxal-silica surfaces; Langmuir-Blodgett technique; Surface interactions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology
  • Antimicrobial Peptides / chemistry*
  • Cathelicidins / chemistry*
  • Cathelicidins / pharmacology
  • Chitosan / chemistry
  • Chitosan / pharmacology
  • Humans
  • Lipids / antagonists & inhibitors*
  • Lipids / chemistry
  • Membrane Lipids / antagonists & inhibitors
  • Microbial Sensitivity Tests
  • Peptide Fragments / chemistry*
  • Peptide Fragments / pharmacology
  • Spectroscopy, Fourier Transform Infrared
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / pathogenicity

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Peptides
  • Cathelicidins
  • Lipids
  • Membrane Lipids
  • Peptide Fragments
  • cathelicidin LL-37 (18-29), human
  • Chitosan